Interleukin-1β induced by Helicobacter pylori infection enhances mouse gastric carcinogenesis

Cancer Letters

Volumn 340, Issue 1, 2013, Pages 141-147

  Shigematsu, Yasuyuki ^a   Niwa, Tohru ^a   Rehnberg, Emil ^a   Toyoda, Takeshi ^b   Yoshida, Satoshi ^a   Mori, Akiko ^a   Wakabayashi, Mika ^a   Iwakura, Yoichiro ^c   Ichinose, Masao ^d   Kim, Yong Joon ^e   Ushijima, Toshikazu ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

^c TOKYO UNIVERSITY OF SCIENCE   (Japan)

^d WAKAYAMA MEDICAL UNIVERSITY   (Japan)

^e Yonsei University   (South Korea)

Author keywords

Gastric cancer; Helicobacter pylori infection; Inflammation; Interleukin 1

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; MESSENGER RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CARCINOGENICITY; CELL PROLIFERATION; CONTROLLED STUDY; EPITHELIUM CELL; GASTRITIS; HELICOBACTER INFECTION; IL1B GENE; INTRACELLULAR SIGNALING; MACROPHAGE MIGRATION; MOLECULAR PATHOLOGY; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; STOMACH CARCINOGENESIS; STOMACH CARCINOMA;

GASTRIC CANCER; GC; HELICOBACTER PYLORI; HELICOBACTER PYLORI INFECTION; HP; IHC; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INTERLEUKIN-1Β; MNU; N-METHYL-N-NITROSOUREA; NF-ΚB; NUCLEAR FACTOR-ΚB;

ANIMALS; APOPTOSIS; CARCINOGENESIS; CELL PROLIFERATION; EPITHELIAL CELLS; GASTRIC MUCOSA; GENE EXPRESSION; HELICOBACTER INFECTIONS; IMMUNITY, CELLULAR; INTERLEUKIN-1BETA; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; NF-KAPPA B; STOMACH NEOPLASMS; TRANSCRIPTIONAL ACTIVATION;

HELICOBACTER PYLORI; MUS;

EID: 84883753150     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2013.07.034     Document Type: Article

References (58)

1. Jemal A., Bray F., Center M.M., Ferlay J., Ward E., Forman D. Global cancer statistics. CA Cancer J. Clin. 2011, 61:69-90.
2. Correa P., Haenszel W., Cuello C., Zavala D., Fontham E., Zarama G., Tannenbaum S., Collazos T., Ruiz B. Gastric precancerous process in a high risk population: cross-sectional studies. Cancer Res. 1990, 50:4731-4736.
3. Correa P., Haenszel W., Cuello C., Zavala D., Fontham E., Zarama G., Tannenbaum S., Collazos T., Ruiz B. Gastric precancerous process in a high risk population: cohort follow-up. Cancer Res. 1990, 50:4737-4740.
4. Fox J.G., Wang T.C. Helicobacter pylori-not a good bug after all!. N. Engl. J. Med. 2001, 345:829-832.
5. Uemura N., Okamoto S., Yamamoto S., Matsumura N., Yamaguchi S., Yamakido M., Taniyama K., Sasaki N., Schlemper R.J. Helicobacter pylori infection and the development of gastric cancer. N. Engl. J. Med. 2001, 345:784-789.
6. Polk D.B., Peek R.M. Helicobacter pylori: gastric cancer and beyond. Nat. Rev. Cancer 2010, 10:403-414.
7. Azuma T. Helicobacter pylori CagA protein variation associated with gastric cancer in Asia. J. Gastroenterol. 2004, 39:97-103.
8. El-Omar E.M., Carrington M., Chow W.H., McColl K.E., Bream J.H., Young H.A., Herrera J., Lissowska J., Yuan C.C., Rothman N., Lanyon G., Martin M., Fraumeni J.F., Rabkin C.S. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 2000, 404:398-402.
9. Yuzhalin A. The role of interleukin DNA polymorphisms in gastric cancer. Hum. Immunol. 2011, 72:1128-1136.
10. El-Omar E.M., Rabkin C.S., Gammon M.D., Vaughan T.L., Risch H.A., Schoenberg J.B., Stanford J.L., Mayne S.T., Goedert J., Blot W.J., Fraumeni J.F., Chow W.H. Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms. Gastroenterology 2003, 124:1193-1201.
11. Zambon C.F., Basso D., Navaglia F., Falda A., Belluco C., Fogar P., Greco E., Gallo N., Farinati F., Cardin R., Rugge M., Di Mario F., Plebani M. Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms. Gastroenterology 2004, 126:382-384.
12. Loh M., Koh K.X., Yeo B.H., Song C.M., Chia K.S., Zhu F., Yeoh K.G., Hill J., Iacopetta B., Soong R. Meta-analysis of genetic polymorphisms and gastric cancer risk: variability in associations according to race. Eur. J. Cancer 2009, 45:2562-2568.
13. Taguchi A., Ohmiya N., Shirai K., Mabuchi N., Itoh A., Hirooka Y., Niwa Y., Goto H. Interleukin-8 promoter polymorphism increases the risk of atrophic gastritis and gastric cancer in Japan. Cancer Epidemiol. Biomarkers Prev. 2005, 14:2487-2493.
14. Hamajima N., Naito M., Kondo T., Goto Y. Genetic factors involved in the development of Helicobacter pylori-related gastric cancer. Cancer Sci. 2006, 97:1129-1138.
15. Figueiredo C., Machado J.C., Pharoah P., Seruca R., Sousa S., Carvalho R., Capelinha A.F., Quint W., Caldas C., van Doorn L.J., Carneiro F., Sobrinho-Simoes M. Helicobacter pylori and interleukin 1 genotyping: an opportunity to identify high-risk individuals for gastric carcinoma. J. Natl. Cancer Inst. 2002, 94:1680-1687.
16. Lee K.A., Ki C.S., Kim H.J., Sohn K.M., Kim J.W., Kang W.K., Rhee J.C., Song S.Y., Sohn T.S. Novel interleukin 1beta polymorphism increased the risk of gastric cancer in a Korean population. J. Gastroenterol. 2004, 39:429-433.
17. Kimura R., Nishioka T., Soemantri A., Ishida T. Cis-acting effect of the IL1B C-31T polymorphism on IL-1 beta mRNA expression. Genes Immun. 2004, 5:572-575.
18. Rad R., Dossumbekova A., Neu B., Lang R., Bauer S., Saur D., Gerhard M., Prinz C. Cytokine gene polymorphisms influence mucosal cytokine expression, gastric inflammation, and host specific colonisation during Helicobacter pylori infection. Gut 2004, 53:1082-1089.
19. Yang J., Hu Z., Xu Y., Shen J., Niu J., Hu X., Guo J., Wei Q., Wang X., Shen H. Interleukin-1B gene promoter variants are associated with an increased risk of gastric cancer in a Chinese population. Cancer Lett. 2004, 215:191-198.
20. Palli D., Saieva C., Luzzi I., Masala G., Topa S., Sera F., Gemma S., Zanna I., D'Errico M., Zini E., Guidotti S., Valeri A., Fabbrucci P., Moretti R., Testai E., del Giudice G., Ottini L., Matullo G., Dogliotti E., Gomez-Miguel M.J. Interleukin-1 gene polymorphisms and gastric cancer risk in a high-risk Italian population. Am. J. Gastroenterol. 2005, 100:1941-1948.
21. Kumar S., Kumar A., Dixit V.K. Evidences showing association of interleukin-1B polymorphisms with increased risk of gastric cancer in an Indian population. Biochem. Biophys. Res. Commun. 2009, 387:456-460.
22. Kamangar F., Cheng C., Abnet C.C., Rabkin C.S. Interleukin-1B polymorphisms and gastric cancer risk - a meta-analysis. Cancer Epidemiol. Biomarkers Prev. 2006, 15:1920-1928.
23. Wex T., Leodolter A., Bornschein J., Kuester D., Kahne T., Kropf S., Albrecht C., Naumann M., Roessner A., Malfertheiner P. Interleukin 1 beta (IL1B) gene polymorphisms are not associated with gastric carcinogenesis in Germany. Anticancer Res. 2010, 30:505-511.
24. He B., Zhang Y., Pan Y., Xu Y., Gu L., Chen L., Wang S. Interleukin 1 beta (IL1B) promoter polymorphism and cancer risk: evidence from 47 published studies. Mutagenesis 2011, 26:637-642.
25. Kato S., Onda M., Yamada S., Matsuda N., Tokunaga A., Matsukura N. Association of the interleukin-1 beta genetic polymorphism and gastric cancer risk in Japanese. J. Gastroenterol. 2001, 36:696-699.
26. Persson C., Canedo P., Machado J.C., El-Omar E.M., Forman D. Polymorphisms in inflammatory response genes and their association with gastric cancer: a HuGE systematic review and meta-analyses. Am. J. Epidemiol. 2010, 173:259-270.
27. Tu S., Bhagat G., Cui G., Takaishi S., Kurt-Jones E.A., Rickman B., Betz K.S., Penz-Oesterreicher M., Bjorkdahl O., Fox J.G., Wang T.C. Overexpression of interleukin-1beta induces gastric inflammation and cancer and mobilizes myeloid-derived suppressor cells in mice. Cancer Cell 2008, 14:408-419.
28. Tsukamoto T., Mizoshita T., Tatematsu M. Animal models of stomach carcinogenesis. Toxicol. Pathol. 2007, 35:636-648.
29. Han S.U., Kim Y.B., Joo H.J., Hahm K.B., Lee W.H., Cho Y.K., Kim D.Y., Kim M.W. Helicobacter pylori infection promotes gastric carcinogenesis in a mice model. J. Gastroenterol. Hepatol. 2002, 17:253-261.
30. Sakamoto K., Hikiba Y., Nakagawa H., Hayakawa Y., Yanai A., Akanuma M., Ogura K., Hirata Y., Kaestner K.H., Omata M., Maeda S. Inhibitor of kappaB kinase beta regulates gastric carcinogenesis via interleukin-1alpha expression. Gastroenterology 2010, 139:226-238.
31. Tatematsu M., Ogawa K., Hoshiya T., Shichino Y., Kato T., Imaida K., Ito N. Induction of adenocarcinomas in the glandular stomach of BALB/c mice treated with N-methyl-N-nitrosourea. Jpn. J. Cancer Res. 1992, 83:915-918.
32. Tatematsu M., Yamamoto M., Iwata H., Fukami H., Yuasa H., Tezuka N., Masui T., Nakanishi H. Induction of glandular stomach cancers in C3H mice treated with N-methyl-N-nitrosourea in the drinking water. Jpn. J. Cancer Res. 1993, 84:1258-1264.
33. Horai R., Asano M., Sudo K., Kanuka H., Suzuki M., Nishihara M., Takahashi M., Iwakura Y. Production of mice deficient in genes for interleukin (IL)-1alpha, IL-1beta, IL-1alpha/beta, and IL-1 receptor antagonist shows that IL-1beta is crucial in turpentine-induced fever development and glucocorticoid secretion. J. Exp. Med. 1998, 187:1463-1475.
34. Lee A., O'Rourke J., De Ungria M.C., Robertson B., Daskalopoulos G., Dixon M.F. A standardized mouse model of Helicobacter pylori infection: introducing the Sydney strain. Gastroenterology 1997, 112:1386-1397.
35. Hur K., Niwa T., Toyoda T., Tsukamoto T., Tatematsu M., Yang H.K., Ushijima T. Insufficient role of cell proliferation in aberrant DNA methylation induction and involvement of specific types of inflammation. Carcinogenesis 2011, 32:35-41.
36. Eliceiri K.W., Berthold M.R., Goldberg I.G., Ibanez L., Manjunath B.S., Martone M.E., Murphy R.F., Peng H., Plant A.L., Roysam B., Stuurmann N., Swedlow J.R., Tomancak P., Carpenter A.E. Biological imaging software tools. Nat. Methods 2012, 9:697-710.
37. Katsurano M., Niwa T., Yasui Y., Shigematsu Y., Yamashita S., Takeshima H., Lee M.S., Kim Y.J., Tanaka T., Ushijima T. Early-stage formation of an epigenetic field defect in a mouse colitis model, and non-essential roles of T- and B-cells in DNA methylation induction. Oncogene 2012, 31:342-351.
38. Takeshima H., Ikegami D., Wakabayashi M., Niwa T., Kim Y.J., Ushijima T. Induction of aberrant trimethylation of histone H3 lysine 27 by inflammation in mouse colonic epithelial cells. Carcinogenesis 2012.
39. Niwa T., Tsukamoto T., Toyoda T., Mori A., Tanaka H., Maekita T., Ichinose M., Tatematsu M., Ushijima T. Inflammatory processes triggered by Helicobacter pylori infection cause aberrant DNA methylation in gastric epithelial cells. Cancer Res. 2010, 70:1430-1440.
40. Oshima H., Hioki K., Popivanova B.K., Oguma K., Van Rooijen N., Ishikawa T.O., Oshima M. Prostaglandin E(2) signaling and bacterial infection recruit tumor-promoting macrophages to mouse gastric tumors. Gastroenterology 2011, 140:596-607.
41. Du Y.C., Oshima H., Oguma K., Kitamura T., Itadani H., Fujimura T., Piao Y.S., Yoshimoto T., Minamoto T., Kotani H., Taketo M.M., Oshima M. Induction and down-regulation of Sox17 and its possible roles during the course of gastrointestinal tumorigenesis. Gastroenterology 2009, 137:1346-1357.
42. Basso D., Scrigner M., Toma A., Navaglia F., Di Mario F., Rugge M., Plebani M. Helicobacter pylori infection enhances mucosal interleukin-1 beta, interleukin-6, and the soluble receptor of interleukin-2. Int. J. Clin. Lab Res. 1996, 26:207-210.
43. Yamaoka Y., Kita M., Kodama T., Sawai N., Kashima K., Imanishi J. Induction of various cytokines and development of severe mucosal inflammation by cagA gene positive Helicobacter pylori strains. Gut 1997, 41:442-451.
44. Peek R.M., Miller G.G., Tham K.T., Perez-Perez G.I., Zhao X., Atherton J.C., Blaser M.J. Heightened inflammatory response and cytokine expression in vivo to cagA+ Helicobacter pylori strains. Lab Invest. 1995, 73:760-770.
45. Buss H., Dorrie A., Schmitz M.L., Hoffmann E., Resch K., Kracht M. Constitutive and interleukin-1-inducible phosphorylation of p65 NF-{kappa}B at serine 536 is mediated by multiple protein kinases including I{kappa}B kinase (IKK)-{alpha}, IKK{beta}, IKK{epsilon}, TRAF family member-associated (TANK)-binding kinase 1 (TBK1), and an unknown kinase and couples p65 to TATA-binding protein-associated factor II31-mediated interleukin-8 transcription. J. Biol. Chem. 2004, 279:55633-55643.
46. Hwang I.R., Kodama T., Kikuchi S., Sakai K., Peterson L.E., Graham D.Y., Yamaoka Y. Effect of interleukin 1 polymorphisms on gastric mucosal interleukin 1beta production in Helicobacter pylori infection. Gastroenterology 2002, 123:1793-1803.
47. A. Weber, P. Wasiliew, M. Kracht, Interleukin-1 (IL-1) pathway, Sci Signal 3 (2010) cm1.
48. Lee J.K., Kim S.H., Lewis E.C., Azam T., Reznikov L.L., Dinarello C.A. Differences in signaling pathways by IL-1beta and IL-18. Proc. Natl. Acad. Sci. USA 2004, 101:8815-8820.
49. Kim J.M., Kim J.S., Jung H.C., Oh Y.K., Chung H.Y., Lee C.H., Song I.S. Helicobacter pylori infection activates NF-kappaB signaling pathway to induce iNOS and protect human gastric epithelial cells from apoptosis. Am. J. Physiol. Gastrointest Liver Physiol. 2003, 285:G1171-1180.
50. Keates S., Hitti Y.S., Upton M., Kelly C.P. Helicobacter pylori infection activates NF-kappa B in gastric epithelial cells. Gastroenterology 1997, 113:1099-1109.
51. Millet I., Phillips R.J., Sherwin R.S., Ghosh S., Voll R.E., Flavell R.A., Vignery A., Rincon M. Inhibition of NF-kappaB activity and enhancement of apoptosis by the neuropeptide calcitonin gene-related peptide. J. Biol. Chem. 2000, 275:15114-15121.
52. Ben-Neriah Y., Karin M. Inflammation meets cancer, with NF-kappaB as the matchmaker. Nat. Immunol. 2011, 12:715-723.
53. Dinarello C.A. Immunological and inflammatory functions of the interleukin-1 family. Annu. Rev. Immunol. 2009, 27:519-550.
54. Basak C., Pathak S.K., Bhattacharyya A., Mandal D., Pathak S., Kundu M. NF-kappaB- and C/EBPbeta-driven interleukin-1beta gene expression and PAK1-mediated caspase-1 activation play essential roles in interleukin-1beta release from Helicobacter pylori lipopolysaccharide-stimulated macrophages. J. Biol. Chem. 2005, 280:4279-4288.
55. Fehlings M., Drobbe L., Moos V., Renner Viveros P., Hagen J., Beigier-Bompadre M., Pang E., Belogolova E., Churin Y., Schneider T., Meyer T.F., Aebischer T., Ignatius R. Comparative analysis of the interaction of Helicobacter pylori with human dendritic cells, macrophages, and monocytes. Infect Immun. 2012, 80:2724-2734.
56. Kholmanskikh O., van Baren N., Brasseur F., Ottaviani S., Vanacker J., Arts N., van der Bruggen P., Coulie P., De Plaen E. Interleukins 1alpha and 1beta secreted by some melanoma cell lines strongly reduce expression of MITF-M and melanocyte differentiation antigens. Int. J. Cancer 2010, 127:1625-1636.
57. Krelin Y., Voronov E., Dotan S., Elkabets M., Reich E., Fogel M., Huszar M., Iwakura Y., Segal S., Dinarello C.A., Apte R.N. Interleukin-1beta-driven inflammation promotes the development and invasiveness of chemical carcinogen-induced tumors. Cancer Res. 2007, 67:1062-1071.
58. Zitvogel L., Kepp O., Galluzzi L., Kroemer G. Inflammasomes in carcinogenesis and anticancer immune responses. Nat. Immunol. 2012, 13:343-351.